Kymera Therapeutics

Kymera Therapeutics to Present at Upcoming May Investor Conferences

WATERTON, Mass., May 04, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced that the Company will present at the upcoming